Company / Working Capital per Share
Biogen Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$38.82
FY2025
5-year range
$13.39 / $42.77
FY2021-FY2025
Trend
+189.9%
vs FY2024
Sector context
#8 of 212
Health Care
What the data says
Among 212 Health Care companies, Biogen is in the top 4% for working capital per share. Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $38.82.
Based on SEC 10-K filings.
38.82 in FY2025 with a 5-year CAGR of +19.5%. Top quartile in the Health Care sector.
Improved from $23.30 to $38.82 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 212This company $38.82 Sector average $117.56
▼
-67.0% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 189.9% year-over-year.
- Ranks #8 out of 212 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.82 | +189.9% |
| FY2024 | $13.39 | -42.5% |
| FY2023 | $23.30 | -45.5% |
| FY2022 | $42.77 | +109.4% |
| FY2021 | $20.43 | +28.1% |
| FY2020 | $15.95 | -4.1% |
| FY2019 | $16.63 | -17.4% |
| FY2018 | $20.13 | -3.5% |
| FY2017 | $20.87 | -14.1% |
| FY2016 | $24.30 | +38.3% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026